Literature DB >> 939

Letter: beta-Blockers and myasthenia gravis.

Y Herishanu, P Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 939     DOI： 10.7326/0003-4819-83-6-834

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  Myasthenic crisis.

Authors:  David Lacomis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management.

Authors:  Fiammetta Vanoli; Renato Mantegazza
Journal:  Neurotherapeutics       Date:  2022-02-14       Impact factor: 6.088

Review 3.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

4.  Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers.

Authors:  Y Imai; N Watanabe; J Hashimoto; A Nishiyama; H Sakuma; H Sekino; K Omata; K Abe
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review.

Authors:  Tsubasa Takizawa; Marenori Kojima; Shigeaki Suzuki; Takashi Osada; Satoshi Kitagawa; Jin Nakahara; Shinichi Takahashi; Norihiro Suzuki
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.